Hígado graso no alcohólico como factor de riesgo de preeclampsia en gestantes atendidas en el Hospital Regional de Loreto periodo 2020 a 2023
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de la Amazonía Peruana
Abstract
Se llevará a cabo un estudio para determinar si el hígado graso no alcohólico es factor de riesgo de preeclampsia en gestantes atendidas en el Hospital Regional de Loreto periodo 2020 a 2023, por medio de un estudio analítico, observacional, retrospectivo de cohortes; en una población de gestantes atendidas en el Servicio de Obstetricia del Hospital Regional de Loreto durante el período 2020 a 2023, que alcanzan un número de 596 pacientes; se hará uso del estadístico chi cuadrado; considerando significancia si el azar es menor al 5% (p < 0.05) y el riesgo relativo y el análisis multivariado.
A study will be carried out to determine if non-alcoholic fatty liver disease is a risk factor for preeclampsia in pregnant women treated at the Hospital Regional of Loreto period 2020 to 2023, through an analytical, observational, retrospective cohort study; in a population of pregnant women treated in the Obstetrics Service of the Hospital Regional of Loreto during the period 2020 to 2023, reaching a number of 596 patients; for the statistical analysis, the information collected will be tabulated and the results of the instruments used will be interpreted; frequency distribution data will be obtained for the qualitative variables; the chi-square statistic will be used; significance will be considered if the chance is less than 5% (p < 0.05), and relative risk and multivariate analysis.
A study will be carried out to determine if non-alcoholic fatty liver disease is a risk factor for preeclampsia in pregnant women treated at the Hospital Regional of Loreto period 2020 to 2023, through an analytical, observational, retrospective cohort study; in a population of pregnant women treated in the Obstetrics Service of the Hospital Regional of Loreto during the period 2020 to 2023, reaching a number of 596 patients; for the statistical analysis, the information collected will be tabulated and the results of the instruments used will be interpreted; frequency distribution data will be obtained for the qualitative variables; the chi-square statistic will be used; significance will be considered if the chance is less than 5% (p < 0.05), and relative risk and multivariate analysis.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwised noted, this item's license is described as info:eu-repo/semantics/openAccess

